Infectious bronchitis virus causes devastating losses to the poultry industry but scientists are now developing a new way to vaccinate chicks against the disease — one that can be delivered while they are still in their egg. Researchers have used a “reverse genetic” system to produce a new vaccine strain which is safe to deliver to chicks while they are still in the egg, making it more effective than current vaccines.
The U.S. Department of Agriculture’s Agricultural Research Service (ARS) scientists evaluated cattle that have been genetically modified so they do not produce prions, and determined that there were no observable adverse effects on the animals’ health. These genetically engineered cattle would not get mad cow disease.
Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced Otsuka has been granted exclusive rights in Japan to develop and commercialize the investigational compound saxagliptin, being studied for the treatment of Type 2 diabetes. Saxagliptin, discovered by Bristol-Myers Squibb, is a dipeptidyl peptidase-4 (DPP-4) inhibitor currently in Phase III development in the United States and Europe.
National AIDS Research Institute (NARI), Pune, is conducting a first phase of clinical trial of a newly developed HIV/AIDS vaccine. This ongoing trial is being done under the joint auspices of the National AIDS Control Organization (NACO), the Indian Council of Medical Research (ICMR) and the International AIDS Vaccine Initiative (IAVI).
Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it has submitted a complete response to the approvable letter issued by the U.S. Food and Drug Administration (FDA) for the Company?s once-daily formulation of tramadol.
Although online virtual experiences may improve a consumer’s knowledge of a product, the marketing tactic can backfire by creating a false sense of what the product’s real capabilites are, says a University of Washington professor of marketing.
Eli Lilly and Company (NYSE: LLY), vigorously objects to the characterization of company practices in a New York Times article based upon selective documents illegally leaked by plaintiffs’ lawyers.
Testing for deadly food, air and water pathogens may get a lot easier and cheaper thanks to the work of a Michigan State University researcher and his team. Syed Hashsham, an associate professor in the Department of Civil and Environmental Engineering and the Center for Microbial Ecology, is developing a portable, hand-held device capable of detecting up to 50 microbial threat agents in air, water and food
Biophan Technologies, Inc., a developer of next-generation medical technology, in conjunction with MYOTECH, LLC, recently presented results of animal studies that indicate the potential of the MYO-VAD, a cardiac support system to significantly improve the treatment of heart failure. The MYO-VAD restores cardiac output on an arrested or weak heart. The device can be implanted in approximately three minutes.
US Health officials on Wednesday zeroed in on lettuce as the likely suspect in the E coli outbreak linked to Taco Bell, though tracing the vegetable’s source may prove difficult.